ZEOX (Zeo ScientifiX) Stock Based Compensation: $3.69 Mil (TTM As of Apr. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

ZEOX Zeo ScientifiX Inc ZEOX
54 GF Score
Price $1.89
GF Value $2.66
Valuation Modestly Undervalued
! 5 Warning Signs
View Full Analysis

What is Zeo ScientifiX Stock Based Compensation?

Zeo ScientifiX ZEOX -5.65% 54 Stock Based Compensation is $3.69 Mil as of Apr. 2026. GuruFocus rates ZEOX with a GF Score™ of 54/100 and a GF Value™ of $2.66 (Modestly Undervalued). The stock has 5 warning signs investors should review.

Zeo ScientifiX's Stock Based Compensation for the three months ended in Apr. 2026 was $0.59 Mil. Its Stock Based Compensation for the trailing twelve months (TTM) ended in Apr. 2026 was $3.69 Mil.

Zeo ScientifiX Stock Based Compensation Related Terms

Zeo ScientifiX Stock Based Compensation Historical Data

* Premium members only.

The historical data trend for Zeo ScientifiX's Stock Based Compensation can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Zeo ScientifiX Stock Based Compensation Chart

Zeo ScientifiX Annual Data
Trend Oct16 Oct17 Oct18 Oct19 Oct20 Oct21 Oct22 Oct23 Oct24 Oct25
Stock Based Compensation
Get a 7-Day Free Trial Premium Member Only Premium Member Only 8.65 3.92 3.21 3.85 4.69

Zeo ScientifiX Quarterly Data
Jul21 Oct21 Jan22 Apr22 Jul22 Oct22 Jan23 Apr23 Jul23 Oct23 Jan24 Apr24 Jul24 Oct24 Jan25 Apr25 Jul25 Oct25 Jan26 Apr26
Stock Based Compensation Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1.10 1.75 0.76 0.59 0.59
ZEOX
54GF Score
Zeo ScientifiX Inc ZEOX
Stock Based Compensation is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Zeo ScientifiX Stock Based Compensation Calculation

Stock Based Compensation is a way corporations use stock options to reward employees. It provides executives and employees the opportunity to share in the growth of the company and, if structured properly, can align their interests with the interests of the company's shareholders and investors, without burning the company's cash on hand.

Stock Based Compensation for the trailing twelve months (TTM) ended in Apr. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $3.69 Mil.

What does a Stock Based Compensation of $3.69 Mil mean?
Zeo ScientifiX (ZEOX) has a Stock Based Compensation of $3.69 Mil as of Apr. 2026. Stock based compensation is the amount of company stock issued as employee benefits. View historical data for Zeo ScientifiX and its competitors.
Is Zeo ScientifiX's Stock Based Compensation too high?
Zeo ScientifiX's current Stock Based Compensation is $3.69 Mil. Overall, Zeo ScientifiX has a GF Score™ of 54/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Zeo ScientifiX's Stock Based Compensation compare to JUNS and HOOK?
Zeo ScientifiX's Stock Based Compensation of $3.69 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Stock Based Compensation for a Biotechnology company?
A good Stock Based Compensation depends on the Biotechnology industry context. However, Stock Based Compensation should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Stock Based Compensation mean?
A high Stock Based Compensation can signal that a stock is expensive relative to its fundamentals. Stock based compensation is the amount of company stock issued as employee benefits. View historical data for Zeo ScientifiX and its competitors. Zeo ScientifiX's current Stock Based Compensation is $3.69 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Zeo ScientifiX stock overvalued right now?
Based on GuruFocus' analysis, Zeo ScientifiX (ZEOX) is currently considered Modestly Undervalued. The stock's GF Value™ is $2.66, compared to a current price of $1.89 — trading 29.1% below its estimated fair value. The current Stock Based Compensation is $3.69 Mil. Zeo ScientifiX's overall GF Score™ is 54/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Stock Based Compensation calculated?
Stock Based Compensation is calculated from a company's financial statements. For Zeo ScientifiX (ZEOX), the current Stock Based Compensation is $3.69 Mil as of Apr. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Zeo ScientifiX (ZEOX) Overvalued in 2026?

Based on GuruFocus' analysis, Zeo ScientifiX stock appears to be undervalued. The current stock price of $1.89 is trading 29.1% below its estimated GF Value™ of $2.66. GuruFocus considers Zeo ScientifiX to be Modestly Undervalued.

Key valuation signals for ZEOX:

  • Stock Based Compensation: $3.69 Mil
  • GF Value™: $2.66 vs. price of $1.89 (29.1% below fair value)
  • GF Score™: 54/100 with 5 warning signs

No single metric tells the full story. See the ZEOX stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Zeo ScientifiX Business Description

Address 3321 College Avenue, Suite 246, Davie, FL, USA, 33314
Zeo ScientifiX Inc is a clinical-stage biopharmaceutical company located inside Nova Southeastern University's Collaborative Center for Research in Davie, Florida. The Company is a clinical-stage biopharmaceutical company principally focusing on the development of biological therapeutics for the treatment of degenerative diseases and regenerative medicine. The Company's proprietary products, including Zofin, are derived from perinatal sources and manufactured to retain the naturally occurring extracellular vesicles, proteins and cell secreted nanoparticles and Patient Pure X (PPX ), an autologous biologic containing a nanoparticle fraction that is precipitated from a patient's own peripheral blood (RAAM Products).
54GF Score

Get the complete analysis for ZEOX

Stock Based Compensation is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$1.89
Price
$2.66
GF Value